Immuno-Oncology-The Translational Runway for Gene Therapy: Gene Therapeutics to Address Multiple Immune Targets

Area of Science:

• Oncology
• Immunology
• Gene Therapy

Background:

• Traditional cancer therapies focusing on single targets are insufficient for lasting tumor eradication.
• Cancer cells effectively evade and deactivate the immune system, necessitating new therapeutic strategies.
• The paradigm is shifting towards harnessing the immune system's power in cancer treatment.

Purpose of the Study:

• To review the role of gene therapy technologies in the advancement of immuno-oncology.
• To highlight gene therapy as a key driver for developing effective cancer immunotherapies.
• To discuss current challenges and breakthroughs in gene therapy for cancer treatment.

Main Methods:

• Review of current literature and clinical advancements in immuno-oncology.
• Analysis of gene therapy applications in various cancer treatment modalities.
• Spotlighting breakthroughs including CAR T-cell therapy, oncolytic viruses, and RNA therapeutics.

Main Results:

• Gene therapy enables parallel targeting of diverse immune cells and mechanisms, overcoming limitations of single-target approaches.
• Gene therapy is identified as a crucial technology for advancing cancer immunotherapy.
• Significant progress has been made in gene-modified therapies, including CAR T-cells and oncolytic viruses.

Conclusions:

• Gene therapy represents a major advancement in immuno-oncology, enabling more comprehensive and effective cancer treatment strategies.
• The future of cancer immunotherapy lies in integrated approaches driven by gene therapy technologies.
• Gene therapy is pivotal for overcoming tumor immune evasion and achieving durable responses.